Skip to main content
Premium Trial:

Request an Annual Quote

Steve Burrill, Donna Marino, Lorah Perlee, Robert Tuttle, BioMerieux, International Tandem Repeat Consortium



Steve Burrill has resigned as a director of Clinical Data, effective immediately, the company said last week in a statement.

"Steve has now been requested by his partners to limit his board commitments and participation only to companies in which Burrill & Company has a substantial financial interest," Randal Kirk, chairman of Clinical Data's board, said in the statement.

HistoRx has added three senior managers to focus on its Aqua platform, the company announced last week.

The new team includes Donna Marino, vice president of diagnostics, Lorah Perlee, president of technical operations, and Robert Tuttle, director of bioinformatics.

Marino comes to HistoRx from Genomic Healthcare Strategies, where she was a principal. She has also worked at the Unite Acquisition Group, Unilever, Grand Metropolitan, and Laderle Laboratories. At HistoRx she will lead the diagnostics business unit and hire a team to bring the tests to market.

Perlee was previously director of scientific applications at Protedyne. She has also held positions at Molecular Staging, Diagxotics, and Lifecodes. At HistoRx, Perlee will oversee core services.

Tuttle was previously at CuraGen as bioinformatics systems manager. He has held senior positions at Turbogenomics and Gerber Scientific. He will lead commercial development of HistoRx's Aqua platform.


New Releases

BioMerieux this week launched its NucliSens EasyQ avian influenza detection test for reference laboratories, the company said this week in a statement. Intended for research purposes, the test can detect both H5 and N1 genetic targets in 90 minutes with the company's NucliSens molecular biology systems, BioMerieux added.

The International Tandem Repeat Consortium this week released a database of tandem genetic repeats at The ITRC said it plans to continue adding tandem repeats from diverse organisms to the database, and to integrate the information into existing genome databases.

Filed under

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.